ABUS vs DD
Arbutus Biopharma Corp (ABUS) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the ABUS and DD stock pages for the full models.
Not investment advice.